선바이오: insider trades · South Korea · DART (FSS)

Discover the full management transaction log of 선바이오, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 선바이오 has recorded 2 public disclosures. Market capitalisation: €86.9bn. The latest transaction was reported on 23 April 2026 — Purchase. Among the most active insiders: 노광. The full history is accessible without an account.